| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/06/2008 | CN101234108A Pharmaceutical composition containing (3S, 2í»R)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof |
| 08/06/2008 | CN101234107A Pharmaceutical composition containing (3S, 2í»S)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof |
| 08/06/2008 | CN100408576C Substd. 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 08/06/2008 | CN100408564C Pyrazole derivatives for treating HIV |
| 08/06/2008 | CN100408093C Use of inhibitor of angiotonin converzyme in preparing pharmaceutical formulations for prevention of stroke, diabetes and/or congestive heart failure |
| 08/06/2008 | CN100408092C Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 08/06/2008 | CN100408051C Quality control method of Chinese medicine composition |
| 08/06/2008 | CN100408047C Medicinal composition of fructose diphosphate sodium and magnesium salt |
| 08/06/2008 | CN100408043C Medicinal composition containing polydatin and its use |
| 08/06/2008 | CN100408038C Use of a vitamin combination for the treatment of primary headaches |
| 08/06/2008 | CN100408035C Use of valsartan or its metabolite to inhibit platelet aggregation |
| 08/05/2008 | US7408064 Neuropeptide y5 antagonist; therapy for eating disorders |
| 08/05/2008 | US7408063 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 08/05/2008 | US7408046 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders |
| 08/05/2008 | US7408037 Polypeptide that, when mixed with a peripheral blood-mononuclear cell culture and incubated, induces cytotoxic T lymphocytes that contain HLA-A2-restricted cytotoxic T lymphocytes; anti-cancer vaccine |
| 08/05/2008 | US7407988 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 08/05/2008 | US7407987 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 08/05/2008 | US7407986 Administering a isothiocyanate, such as sulforaphane, or a glucosinolate; retinal degeneration, Alzheimer's Disease, and aging |
| 08/05/2008 | US7407980 Therapeutic agents for treating central nervous system disorders, incotinence, sexual disorders, NASAL CONGESTION; ALPHA 1 ADRENERGIC AGONISTS; N-[4-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-phenyl]-methanesulfonamide; chemical synthesis by cyclization |
| 08/05/2008 | US7407975 Epothilone derivatives, method for producing same and their pharmaceutical use |
| 08/05/2008 | US7407969 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407963 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 08/05/2008 | US7407954 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407936 Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy |
| 08/05/2008 | US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying |
| 08/05/2008 | US7407933 Containing a mutant angiotensin-converting enzyme that releases glycosylphosphatidylinositol-anchored protein from cell surfaces; for treating a prion-related disease, a bacterial infectious disease or male infertility due to sperm-egg binding insufficiency |
| 08/05/2008 | US7407766 Screening method for agonists or antagonists of semaphorin 6C by determining the effect of a test compound on the interaction between semaphorin 6C and plexin-A1 |
| 08/05/2008 | US7407663 Modified immunodeficiency virus particles |
| 08/05/2008 | CA2404152C Inhibition of cyclooxygenase-2 activity |
| 08/05/2008 | CA2392903C Trans olefinic glucokinase activators |
| 08/05/2008 | CA2388470C Use of carbonylamino derivatives against cns disorders |
| 08/05/2008 | CA2353808C Agent for lowering endothelin levels |
| 08/05/2008 | CA2293549C Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
| 08/05/2008 | CA2290617C Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp |
| 08/05/2008 | CA2281706C Methods and compositions for reducing the incidence of necrotizing enterocolitis |
| 08/05/2008 | CA2224435C Pyrrolopyrimidines and processes for the preparation thereof |
| 08/05/2008 | CA2176649C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 08/05/2008 | CA2161808C Bmp-11 compositions |
| 08/05/2008 | CA2111199C Pharmaceutical formulations of osteogenic proteins |
| 07/31/2008 | WO2008091398A2 Jc virus vaccine |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090940A1 Pharmaceutical agent comprising dopamine d2-like receptor agonist as active ingredient and screening method |
| 07/31/2008 | WO2008090884A1 Novel trifluoromethylphenyltetrahydrocinnoline derivative and pharmaceutical use thereof |
| 07/31/2008 | WO2008090857A1 COMPOUND, α1 ADRENALINE RECEPTOR ANTAGONIST, AND COMPOSITION |
| 07/31/2008 | WO2008090850A1 Agent for enhancing the effect of anticancer agent |
| 07/31/2008 | WO2008090749A1 Agent for modification of sh group |
| 07/31/2008 | WO2008090736A1 Pharmaceutical product for prevention and treatment of alzheimer's dementia |
| 07/31/2008 | WO2008090732A1 Pharmaceutical composition |
| 07/31/2008 | WO2008090717A1 Adam inhibitor |
| 07/31/2008 | WO2008090678A1 Novel peptide |
| 07/31/2008 | WO2008090631A1 Fucoidan-derived oligosaccharide |
| 07/31/2008 | WO2008073961A9 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 07/31/2008 | WO2008073957A3 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 07/31/2008 | WO2008065444A3 Substituted quinazolines |
| 07/31/2008 | WO2008058274A3 Use of resolvins and docosatrienes and analogues thereof for the treatment of angiogenesis and ocular neovascularization |
| 07/31/2008 | WO2008057580A3 Materials and methods for treating and managing angiogenesis-mediated diseases |
| 07/31/2008 | WO2008031061A3 Anti-activin a antibodies and uses thereof |
| 07/31/2008 | WO2008027932A3 Cytochrome p450 oxidase inhibitors and uses thereof |
| 07/31/2008 | WO2007008563A3 Preparation of pegylated conjugates of vla-4 antagonists via a mitsunobu' s reaction |
| 07/31/2008 | US20080182994 Crystallization from solvent; removal of impurities |
| 07/31/2008 | US20080182983 degradation of hyaluronic acid and salt with hydrolase enzymes, to a form a mixture of tetrasaccharide, then applying the mixture to chromatography columns packed with ion exchangers and elution the tetrasaccharides; heat shock protein expression promoters, antiapoptosis, cell and tissue protectants |
| 07/31/2008 | US20080182890 Methods of using low-dose doxepin for the improvement of sleep |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/31/2008 | US20080182873 Process for the manufacture of hmg-coa reductase inhibitors |
| 07/31/2008 | US20080182866 Tetra-Cyclic Carboline Derivatives Useful in the Inhibition of Angiogenesis |
| 07/31/2008 | US20080182846 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | US20080182828 dominant estrogenic activity phase of three daily doses of an estrogen equivalent to 1 mg per day of 17 beta -estradiol per day and a dominant progestagenic activity phase of a combination of an estrogen and a progestogen equivalent to 90 mu g per day of norgestimate; hot flushes |
| 07/31/2008 | US20080182823 E.g., polyethylene glycol-linked alendronate or pamidronate; osteoporosis, osteopenia, urolithiasis, hypercalcemia, Paget's disease, bone metastasis, multiple myeloma, or neoplastic bone lesion |
| 07/31/2008 | US20080182817 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
| 07/31/2008 | US20080182809 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals |
| 07/31/2008 | US20080182803 extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders |
| 07/31/2008 | US20080182798 Novel effectors of dipeptidyl peptidase IV |
| 07/31/2008 | US20080182793 Polypeptide comprising oxidized lipid and/or carbohydrate binding activity for use as tool in diagnosis, prevention and treatment of thrombosis, atherosclerosis, inflammatory and bone disorders |
| 07/31/2008 | US20080182791 Medicament for Improving Prognostic Survival in Therapy of Malignant Tumor |
| 07/31/2008 | US20080182775 Administering analogs of luteinizing hormone-releasing hormone, leuprolide; inhibits testosterone secretion |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182313 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening |
| 07/31/2008 | US20080182292 Investigation of new membrane tubes containing F-actin and myosin of a diameter of 50-400 nm and <50+ micrometers length which span the cells; spreading, incubating and staining with a detectable microscopic stain, fluorescent dye, to obtain stained plasma membranes for 3-D cell microscopy |
| 07/31/2008 | US20080182279 Bacillus crystal protein having improved insecticidal activity; transgenic plant; polynucleotide segment having a sequence region that encodes an insecticidal hybrid delta-endotoxin protein; immunoassay |
| 07/31/2008 | US20080182266 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/31/2008 | US20080181976 Aqueous external preparation for scalp |
| 07/31/2008 | US20080181941 Inert pharmaceutically acceptable substrates containing an analgesic with diameter of .1 mm-3 mm, effective blood levels for at least 24 hours; Opioids; solid dosage form; sustained release |
| 07/31/2008 | US20080181935 Base-treated, detergent-treated telopeptide collagen and a plurality of stem cells; kit for augmenting, bulking or replacing tissue of a mammal |
| 07/31/2008 | US20080181932 inner core comprising an inert material, the outer layer comprising a plurality of pharmaceutically active agents embedded in a matrix, the matrix being substantially erodable when contacted with an aqueous medium |
| 07/31/2008 | US20080181918 Immunogens; vaccines; fusion proteins |
| 07/31/2008 | US20080181907 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia |
| 07/31/2008 | US20080181906 For inducing neutralizing antibodies against HIV; hairpin motif; HIV gp120; hydrogen bonding |
| 07/31/2008 | US20080181898 Wise/sost nucleic acid sequences and amino acid sequences |
| 07/31/2008 | US20080181896 Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers |
| 07/31/2008 | US20080181895 SP16 protein |
| 07/31/2008 | US20080181894 Tumor/cancer antigens; solid phase synthesis; drug screening |
| 07/31/2008 | US20080181888 Polypeptides That Bind Br3 and Uses Thereof |
| 07/31/2008 | US20080181885 202P5A5 gene or fragment or its encoded protein, or variants , or a fragment, used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 202P5A5 be used in active or passive immunization; gene therapy, immunotherapy; anticarcinogenic agent biodrug for pancreatic cancer |
| 07/31/2008 | US20080181884 administering a synergistic mixture comprising an antibody, Anidulafungin (LY303366) and amphotericin B; for drug resistanct infections; induce immunology response; diagnosis of a patient with a Coccidioidomycosis infection |